{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T06:33:09Z","timestamp":1770445989010,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.06.062","type":"journal-article","created":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T05:23:59Z","timestamp":1466486639000},"page":"65-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Management of coronary artery aneurysms using abciximab in children with Kawasaki disease"],"prefix":"10.1016","volume":"220","author":[{"given":"Evangelia","family":"Bachlava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Loukopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Karanasios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Chrousos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1745-1118","authenticated-orcid":false,"given":"Athanasios","family":"Michos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.06.062_bb0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrrheum.2015.54","article-title":"Kawasaki disease: insights into pathogenesis and approaches to treatment","volume":"11","author":"Shulman","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0010","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0020","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0025","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1542\/peds.109.1.e4","article-title":"Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?","volume":"109","author":"Williams","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0030","doi-asserted-by":"crossref","first-page":"e38998","DOI":"10.1371\/journal.pone.0038998","article-title":"Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study","volume":"7","author":"Orenstein","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0735-1097(96)00099-X","article-title":"Sequelae of Kawasaki disease in adolescents and young adults","volume":"28","author":"Burns","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0040","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.CIR.87.5.1776","article-title":"Diagnosis and therapy of Kawasaki disease in children","volume":"87","author":"Dajani","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0045","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","article-title":"Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group","volume":"17","author":"Burns","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0050","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1542\/peds.105.6.e78","article-title":"Initial intravenous gammaglobulin treatment failure in Kawasaki disease","volume":"105","author":"Wallace","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0055","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1007\/s00246-013-0673-9","article-title":"Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period","volume":"34","author":"Giannouli","year":"2013","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/jcpt.12334","article-title":"Kawasaki disease: a comprehensive review of treatment options","volume":"40","author":"Patel","year":"2015","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0065","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2165\/00003495-199856040-00014","article-title":"Abciximab. An updated review of its use in ischaemic heart disease","volume":"56","author":"Foster","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0070","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/(SICI)1097-0304(199811)45:3<264::AID-CCD10>3.0.CO;2-2","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease","volume":"45","author":"Etheridge","year":"1998","journal-title":"Catheter. Cardiovasc. Diagn."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0075","first-page":"242","article-title":"Combination thrombolytic and anti-platelet therapies in an infant with incomplete kawasaki disease and coronary aneurysms","volume":"13","author":"Johnson","year":"2008","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0080","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.amjcard.2010.01.332","article-title":"Does abciximab promote coronary artery remodeling in patients with Kawasaki disease?","volume":"105","author":"McCandless","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0085","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1542\/peds.2004-2182","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"114","author":"Newburger","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/0974-2069.99622","article-title":"The use of Z-scores in paediatric cardiology","volume":"5","author":"Chubb","year":"2012","journal-title":"Ann. Pediatr. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0095","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1253\/circj.CJ-10-74-0903","article-title":"Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)--digest version","volume":"74","author":"Group","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0100","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1253\/circj.CJ-08-0931","article-title":"Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease","volume":"73","author":"Suda","year":"2009","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0105","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/CIRCULATIONAHA.113.002092","article-title":"Bilateral giant coronary aneurysms in Kawasaki disease: how difficult can it be?","volume":"128","author":"Prijic","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0110","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1161\/CIRCULATIONAHA.107.749515","article-title":"Long-term outcome of Kawasaki disease","volume":"118","author":"Senzaki","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.06.062_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0974-2069.107236","article-title":"Anti-platelet agents in pediatric cardiac practice","volume":"6","author":"Mohanty","year":"2013","journal-title":"Ann. Pediatr. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/pgmj.2003.007062","article-title":"Antiplatelet therapy in cardiovascular disease","volume":"80","author":"Behan","year":"2004","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0130","first-page":"192","article-title":"Chemical structures and mode of action of intravenous glycoprotein IIb\/IIIa receptor blockers: a review","volume":"13","author":"Hashemzadeh","year":"2008","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.thromres.2004.12.016","article-title":"Antiplatelet therapy in children","volume":"118","author":"Israels","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0140","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00431-003-1265-0","article-title":"A child with Kawasaki disease who survived after rupture of a coronary artery aneurysm","volume":"162","author":"Mok","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0145","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00246-012-0285-9","article-title":"Extensive coronary aneurysms with thrombosis in resistant Kawasaki disease","volume":"34","author":"Sivakumar","year":"2013","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1089253215573328","article-title":"Successful treatment of myocardial infarction in an infant with Kawasaki disease","volume":"19","author":"Jone","year":"2015","journal-title":"Semin. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.ijcard.2016.06.062_bb0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1047951112000698","article-title":"A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome","volume":"22","author":"Kossiva","year":"2012","journal-title":"Cardiol. Young"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316310683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316310683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T23:23:52Z","timestamp":1536621832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316310683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":31,"alternative-id":["S0167527316310683"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.062","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of coronary artery aneurysms using abciximab in children with Kawasaki disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}